deltatrials

Obsessive-compulsive disorder Trials in Stanford, United States

Conditions / Obsessive-compulsive disorder / Stanford, United States

Research into Obsessive-compulsive disorder spans multiple therapeutic approaches and trial phases.

18 total trials for this combination

Showing top 10 of 18 trials

Trials

NCT ID Title Status Phase
NCT03299166 Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder COMPLETED PHASE2/PHASE3
NCT01674361 A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) COMPLETED PHASE2
NCT03918577 Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders RECRUITING NA
NCT05940324 Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2) RECRUITING
NCT04641143 Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder COMPLETED PHASE3
NCT00004310 Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder UNKNOWN PHASE2
NCT02085057 Neural Links Between OCD and Anorexia COMPLETED
NCT04899687 Study of Dextromethorphan in OCD and Related Disorders RECRUITING PHASE2
NCT04708834 Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder TERMINATED PHASE3
NCT05623306 SEEG-Guided DBS for OCD RECRUITING NA

Related Pages